ArticleJournal of the science of food and agriculture2025
Exploring gastroprotective effect and mechanisms of epigallocatechin gallate-impregnated black garlic in acidic ethanol-induced gastric ulcer model mice.
Article in Journal of the science of food and agriculture, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundPeptic ulcers, particularly gastric ulcers (GUs), are multifactorial disorders with unclear mechanisms. Black garlic (BG) has shown gastroprotective effects. This study evaluated the effects of BG and epigallocatechin gallate-impregnated BG (EG) in acidic ethanol (AE)-induced GU model mice. Mice were pretreated with BG or EG (50-200 mg/kg) for 7 days before ulcer induction. Oral acute toxicity evaluations for BG and EG were also conducted.
resultsOral acute toxicity evaluations showed elevated serum renal function indices at 5 g/kg of BG and 10 g/kg of EG but without histopathological liver or kidney damage. Both BG and EG pretreatments reduced ulcer indices, with EG offering stronger and significant protection. EG pretreatments also showed higher gastric mucosal accumulations. They significantly decreased AE-induced malondialdehyde levels and restored glutathione, superoxide dismutase, and catalase. AE-induced serum levels of tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), interleukin-1 beta (IL-1β), as well as gastric transcript levels of TNF-α, IL-6, IL-1β, cyclooxygenase-2, inducible nitric oxide synthase, and myeloperoxidase, were suppressed. EG further reduced AE-induced phosphorylations of extracellular signal-regulated kinase, c-jun-N-terminal kinase, p38, nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), and inhibitor of κB.
conclusionEG2 showed stronger gastroprotective activity than BG by modulating oxidative stress, inflammatory response, and mitogen-activated protein kinase (MAPK)/NF-κB signaling pathways. This study supports the application of EG as a value-added functional food ingredient for GU prevention. © 2025 The Author(s). Journal of the Science of Food and Agriculture published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.